Bivalirudin versus heparin for percutaneous coronary intervention: an updated meta-analysis of randomized controlled trials

Meta-analysis of 14 RCTs with 30,446 patients demonstrated that bivalirudin is associated with higher risk of stent thrombosis but lower risk of major bleeding compared with heparin.